Hot Pursuit     30-May-24
Zydus Lifesciences Ltd slips for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 1024.9, down 1.9% on the day as on 13:19 IST on the NSE. The stock jumped 104.04% in last one year as compared to a 21.68% rally in NIFTY and a 50.2% spurt in the Nifty Pharma index.

Zydus Lifesciences Ltd is down for a fifth straight session today. The stock is quoting at Rs 1024.9, down 1.9% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 22553.1. The Sensex is at 74074.04, down 0.58%.Zydus Lifesciences Ltd has added around 3.73% in last one month.Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has eased around 0.42% in last one month and is currently quoting at 19321.35, down 1.44% on the day. The volume in the stock stood at 9.12 lakh shares today, compared to the daily average of 18.39 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 1026.7, down 2.05% on the day. Zydus Lifesciences Ltd jumped 104.04% in last one year as compared to a 21.68% rally in NIFTY and a 50.2% spurt in the Nifty Pharma index.

The PE of the stock is 30.5 based on TTM earnings ending March 24.

Previous News
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
  Zydus Lifesciences gains as board mulls share buyback
 ( Hot Pursuit - 06-Feb-24   09:33 )
  Zydus Lifesciences Ltd spurts 2.36%, rises for third straight session
 ( Hot Pursuit - 17-May-24   13:05 )
  Zydus Life rises as Q2 PAT soars 53% YoY to Rs 801 cr
 ( Hot Pursuit - 07-Nov-23   15:23 )
  Zydus Life incorporates wholly owned subsidiary in Canada
 ( Hot Pursuit - 08-Sep-23   14:39 )
  Zydus Lifesciences Ltd spurts 4%, up for fifth straight session
 ( Hot Pursuit - 18-Dec-23   13:00 )
  Zydus receives USFDA approval for Norelgestromin and Ethinyl Estradiol Transdermal System
 ( Corporate News - 15-Sep-23   15:11 )
  Board of Zydus Lifesciences to consider buyback of shares
 ( Corporate News - 05-Feb-24   18:54 )
  Zydus Life gets zero observation from USFDA for Ahmedabad facility
 ( Hot Pursuit - 03-Jun-23   12:33 )
  Zydus Life gets USFDA nod for breast cancer drug
 ( Hot Pursuit - 29-Jun-23   12:17 )
  Zydus Life commences phase IV trial for fatty liver disease drug
 ( Hot Pursuit - 09-Jun-23   10:26 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top